Dr. Stephanie Lee, MD, MPH
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Graft-versus-Host Disease
Studies Bronchiolitis Obliterans Syndrome
6 reported clinical trials
12 drugs studied
Affiliated Hospitals
Clinical Trials Stephanie Lee, MD, MPH is currently running
Ustekinumab
for Preventing Graft-versus-Host Disease in Blood Cancer Patients
This trial studies how well ustekinumab works in preventing complications in patients receiving unrelated donor transplants. Ustekinumab helps control the immune system to stop it from attacking the body's tissues. The goal is to protect patients from complications after their transplant. Ustekinumab has been used in the treatment of autoimmune conditions such as psoriasis, psoriatic arthritis, and Crohn's disease.
Recruiting0 awards Phase 2
Acalabrutinib
for Graft-versus-Host Disease
This phase II trial studies how well acalabrutinib works in treating patients with chronic graft versus host disease. Acalabrutinib may be an effective treatment for graft-versus-host disease caused by a stem cell transplant.
Recruiting1 award Phase 28 criteria
More about Stephanie Lee, MD, MPH
Clinical Trial Related3 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Stephanie Lee, MD, MPH has experience with
- Acalabrutinib
- Belumosudil
- Ustekinumab
- Donor Search Prognosis Score
- Glasdegib
- Biospecimen Collection
Breakdown of trials Stephanie Lee, MD, MPH has run
Graft-versus-Host Disease
Bronchiolitis Obliterans Syndrome
Blood Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephanie Lee, MD, MPH specialize in?
Stephanie Lee, MD, MPH focuses on Graft-versus-Host Disease and Bronchiolitis Obliterans Syndrome. In particular, much of their work with Graft-versus-Host Disease has involved treating patients, or patients who are undergoing treatment.
Is Stephanie Lee, MD, MPH currently recruiting for clinical trials?
Yes, Stephanie Lee, MD, MPH is currently recruiting for 3 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Stephanie Lee, MD, MPH has studied deeply?
Yes, Stephanie Lee, MD, MPH has studied treatments such as Acalabrutinib, Belumosudil, Ustekinumab.
What is the best way to schedule an appointment with Stephanie Lee, MD, MPH?
Apply for one of the trials that Stephanie Lee, MD, MPH is conducting.
What is the office address of Stephanie Lee, MD, MPH?
The office of Stephanie Lee, MD, MPH is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.